TaiMed Biologics Inc.(TW:4147)
NT$61.90+1.60 (+2.65%)
TW:4147
TaiMed Biologics Inc. Revenue
NT$61.90
At close:+1.60 (+2.65%)
TaiMed Biologics Inc. (4147) Revenue
TaiMed Biologics Inc. Revenue
TaiMed Biologics Inc. had a revenue of 155.84M in the quarter ending Jun 30, 2026, with -6.17%. This bring the company's revenue in the last twelve months to 619.49M, Increased 3.04%. In the fiscal year ending Dec 31, 2025, TaiMed Biologics Inc. had annual revenue of 611.35M with 0.19% growth.
- Revenue (ttm)
- 619.49M
- Revenue Growth
- 7.02%
- P/S Ratio
- 26.95
- Revenue/Employee
- TWD 765,144
- Employees
- 799
- Market Cap
- TWD 16.47B
Revenue Chart
TaiMed Biologics Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 611.35M | 1.19M | 0.19% |
| Dec 31, 2024 | 610.16M | 118.39M | 24.07% |
| Dec 31, 2023 | 491.78M | -71.23M | -12.65% |
| Dec 31, 2022 | 563.01M | 149.57M | 36.18% |
| Dec 31, 2021 | 413.44M | -309.04M | -42.78% |
| Dec 31, 2020 | 722.49M | 17.98M | 2.55% |
| Dec 31, 2019 | 704.50M | 463.46M | 192.28% |
| Dec 31, 2018 | 241.04M | 232.60M | 2757.29% |
| Dec 31, 2017 | 8.44M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.